Inhibiting HMGB1 expression improves cognitive function in aged and Alzheimer’s disease mouse models, highlighting the therapeutic potential of targeting HMGB1 in age-related cognitive decline (Gaikwad and Kayed, 2022b). This evidence concerns the gene HMGB1 and early-onset autosomal dominant Alzheimer disease.